Evaluation of the Pharmacokinetics and Safety of VX-548 in Participants With Renal Impairment
Clinical trial NCT05704556 · COMPLETED
Trial details
- NCT number
- NCT05704556
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-27
- Primary completion
- 2024-03-30
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.